# Forward Ventures: portfolio, investments and team > Forward Ventures is an accelerator based in United States. 38 investments on record, latest Aug 2015. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/forward-ventures (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Forward Ventures Last cheque observed Aug 2015. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Quiet Accelerator Seed Series A Series B Transcriptomics Therapeutic Genomics Cheques on record **0%** of best year **0** **cheques in 12 months**, 38 on record Since the last cheque **4081** days **00** hrs **00** min **00** sec Median round **$24M** Rounds led **0 of 38** Sole investor **1 rounds** Exits **7 from the portfolio** Mostly in **United States, 97%** Pitch Forward Ventures ## Forward Ventures highlights - 01 38 rounds on record - 02 Mostly Series B and Series A: 54% of its rounds - 03 Sole investor in 1 rounds, median $17M - 04 7 exits from the portfolio ## What they do > Forward Ventures, founded in 1990, is a leading life-science venture capital firm located in San Diego, with over $450 million under management. From their own website - **Type:** Accelerator (from a list, unverified) - **Cheque size:** Not stated - **Stages:** Seed Series A Series B Growth - **Sectors:** Transcriptomics Therapeutic Genomics - **Based in:** San Diego, United States - **Cold pitches:** Not accepted ## The record Every round we can evidence, newest first **38 appearances** - **2015** 1 round - **Aug** **[Syndax Pharmaceuticals](https://millionrounds.com/company/syndax-pharmaceuticals)** Series C · US **$80M** With 12 others - **2013** 2 rounds - **Sept** **[Affinium Pharmaceuticals](https://millionrounds.com/company/affinium-pharmaceuticals)** Debt · US · canadianprivateequity.com **$12M** With 2 others - **Aug** **[Syndax Pharmaceuticals](https://millionrounds.com/company/syndax-pharmaceuticals)** Series B · US · finsmes.com **$27M** With 3 others - **2012** 2 rounds - **Nov** **[Ambit Biosciences](https://millionrounds.com/company/ambit-biosciences)** Venture · US · phx.corporate-ir.net **$50M** With 8 others - **Mar** **[HemaQuest Pharmaceuticals](https://millionrounds.com/company/hemaquest-pharmaceuticals)** Series B · US · hemaquest.com **$13M** With 4 others - **2011** 2 rounds - **Aug** **[Affinium Pharmaceuticals](https://millionrounds.com/company/affinium-pharmaceuticals)** Series B · US · afnm.com **$15M** With 2 others - **Jun** **[Ambit Biosciences](https://millionrounds.com/company/ambit-biosciences)** Series D · US · phx.corporate-ir.net **$30M** With 9 others - **2010** 5 rounds - **Jun** **[Nereus Pharmaceuticals](https://millionrounds.com/company/nereus-pharmaceuticals)** Series E · US · onbiovc.com **$20M** With 6 others - **Apr** **[HemaQuest Pharmaceuticals](https://millionrounds.com/company/hemaquest-pharmaceuticals)** Series B · US · fiercebiotech.com **$12M** With 3 others - **Mar** **[Syndax Pharmaceuticals](https://millionrounds.com/company/syndax-pharmaceuticals)** Series A · US · onbiovc.com **$9.0M** With 4 others - **Feb** **[Tioga Pharmaceuticals](https://millionrounds.com/company/tioga-pharmaceuticals)** Series A · US · tiogapharma.com **$18M** With 3 others - **Feb** **[Altair Therapeutics](https://millionrounds.com/company/altair-therapeutics)** Series B · US · onbiovc.com **$17M** With 3 others - **2009** 1 round - **Aug** **[LigoCyte Pharmaceuticals](https://millionrounds.com/company/ligocyte-pharmaceuticals)** Series C · US **$29M** With 3 others - **2008** 1 round - **Apr** **[LigoCyte Pharmaceuticals](https://millionrounds.com/company/ligocyte-pharmaceuticals)** Series B · US **$28M** With 3 others - **2007** 9 rounds - **Nov** **[Ambit Biosciences](https://millionrounds.com/company/ambit-biosciences)** Series D · US **$49M** With 11 others - **Nov** **[HemaQuest Pharmaceuticals](https://millionrounds.com/company/hemaquest-pharmaceuticals)** Series A · US **$20M** With 2 others - **Nov** **[Asteres](https://millionrounds.com/company/asteres)** Series C · US · venturedeal.com **$4.0M** With 2 others - **Sept** **[Sequel Pharmaceuticals](https://millionrounds.com/company/sequel-pharmaceuticals)** Series A · US **$20M** With 4 others - **Aug** **[Nereus Pharmaceuticals](https://millionrounds.com/company/nereus-pharmaceuticals)** Series D · US **$45M** With 12 others - **Apr** **[Syndax Pharmaceuticals](https://millionrounds.com/company/syndax-pharmaceuticals)** Series A · US **$40M** With 4 others - **Mar** **[Affinium Pharmaceuticals](https://millionrounds.com/company/affinium-pharmaceuticals)** Series A · US **$18M** With 3 others - **Feb** **[Sanarus Medical](https://millionrounds.com/company/sanarus-medical)** Series E · US · deals.venturebeat.com **$15M** With 6 others - **Jan** **[Proprius Pharmaceuticals](https://millionrounds.com/company/proprius-pharmaceuticals)** Series A · US **$11M** With 4 others - **2006** 3 rounds - **Oct** **[Concurrent Thinking](https://millionrounds.com/company/concurrent-thinking)** Venture · GB **$3.2M** With 2 others - **Sept** **[NovaCardia](https://millionrounds.com/company/novacardia)** Series B · US **$48M** With 5 others - **Jan** **[Tioga Pharmaceuticals](https://millionrounds.com/company/tioga-pharmaceuticals)** Series A · US · tiogapharma.com **$24M** With 2 others - **2005** 4 rounds - **Oct** **[Nereus Pharmaceuticals](https://millionrounds.com/company/nereus-pharmaceuticals)** Series D · US **$43M** With 11 others - **Aug** **[Adiana](https://millionrounds.com/company/adiana)** Series D · US · allbusiness.com **$23M** With 8 others - **May** **[Ambit Biosciences](https://millionrounds.com/company/ambit-biosciences)** Series C · US **$31M** With 6 others - **Jan** **[Predix Pharmaceuticals](https://millionrounds.com/company/predix-pharmaceuticals)** Series C **$43M** With 10 others - **2004** 2 rounds - **Feb** **[Morphotek](https://millionrounds.com/company/morphotek)** Series C · US **$26M** With 9 others - **Jan** **[TargeGen](https://millionrounds.com/company/targegen)** Series B · US **$30M** With 4 others - **2003** 3 rounds - **Nov** **[Sanarus Medical](https://millionrounds.com/company/sanarus-medical)** Series C · US **$19M** With 5 others - **May** **[Acorda Therapeutics](https://millionrounds.com/company/acorda-therapeutics)** Series C · US **$55M** With 6 others - **Mar** **[Hypnion](https://millionrounds.com/company/hypnion)** Series B · US **$48M** With 8 others - **2002** 2 rounds - **Nov** **[Kemia](https://millionrounds.com/company/kemia)** Series A · US **$17M** Sole investor - **Jan** **[Gryphon Therapeutics](https://millionrounds.com/company/gryphon-therapeutics)** Series B **$26M** With 2 others - **2001** 1 round - **Jul** **[Sanarus Medical](https://millionrounds.com/company/sanarus-medical)** Series B · US **$14M** With 3 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team We hold **3** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## Exits from the portfolio Companies it backed that were later bought or listed **7 in all** **[Ambit Biosciences](https://millionrounds.com/company/ambit-biosciences)** Bought by [Daiichi Sankyo](https://millionrounds.com/fund/daiichi-sankyo) **$410M** Sept 2014 **[Affinium Pharmaceuticals](https://millionrounds.com/company/affinium-pharmaceuticals)** Bought by [Debiopharm Group](https://millionrounds.com/fund/debiopharm-innovat) **Undisclosed** Feb 2014 **[LigoCyte Pharmaceuticals](https://millionrounds.com/company/ligocyte-pharmaceuticals)** Bought by [Takeda Pharmaceutical](https://millionrounds.com/fund/takeda-pharmaceutical) **$60M** Oct 2012 **[TargeGen](https://millionrounds.com/company/targegen)** Bought by [Sanofi Aventis](https://millionrounds.com/fund/sanofi) **$635M** Jun 2010 **[NovaCardia](https://millionrounds.com/company/novacardia)** Bought by Merck & Co. **$366M** Sept 2007 **[Hypnion](https://millionrounds.com/company/hypnion)** Bought by Lilly **Undisclosed** Apr 2007 **[Adiana](https://millionrounds.com/company/adiana)** Bought by [Cytyc](https://millionrounds.com/fund/cytyc) **$215M** Feb 2007 An exit counts when it came after the firm's first round in the company. From historical deal records. ## The cheque Seed Series A Series B Median round joined **$24M** the round, not its cheque Alone, median **$17M** Led 0 of 38 rounds **0%** - **Sole investor:** 1 rounds - **Last cheque:** Aug 2015 - **Exits:** 7 from the portfolio Rounds by stage said on their site - Series B said *11* - Series A said *9* - Series C *8* - Series D *5* - Series E *2* - Venture *2* - Seed said *-* Cheques by year Led Joined 2001 2015 Often in the room with - [Domain Associates](https://millionrounds.com/fund/domain-associates) 7 - [Gimv](https://millionrounds.com/fund/gimv) 7 - [MPM Capital](https://millionrounds.com/fund/mpm-bioimpact) 6 - [OrbiMed](https://millionrounds.com/fund/orbimed) 6 - [Roche Venture Fund](https://millionrounds.com/fund/roche-venture-fund) 6 - [Alta Partners](https://millionrounds.com/fund/alta-partners) 5 **Pitching Forward Ventures?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Forward Ventures. A count of rooms they were both in, not a relationship either has claimed. [**Domain Associates** VC firm **7** rounds together](https://millionrounds.com/fund/domain-associates)[**Gimv** Private equity **7** rounds together](https://millionrounds.com/fund/gimv)[**MPM Capital** Private equity **6** rounds together](https://millionrounds.com/fund/mpm-bioimpact)[**OrbiMed** Private equity **6** rounds together](https://millionrounds.com/fund/orbimed)[**Roche Venture Fund** Corporate VC **6** rounds together](https://millionrounds.com/fund/roche-venture-fund)[**Alta Partners** VC firm **5** rounds together](https://millionrounds.com/fund/alta-partners)[**MedImmune Ventures** Corporate VC **5** rounds together](https://millionrounds.com/fund/medimmune-ventures)[**Avalon Ventures** VC firm **4** rounds together](https://millionrounds.com/fund/avalon-ventures)[**InterWest Partners** VC firm **4** rounds together](https://millionrounds.com/fund/interwest-partners)[**Advent International** Private equity **3** rounds together](https://millionrounds.com/fund/advent-international)[**Apposite Capital** VC firm **3** rounds together](https://millionrounds.com/fund/apposite-capital)[**De Novo Ventures** Growth equity **3** rounds together](https://millionrounds.com/fund/de-novo-ventures) ## Quick answers about Forward Ventures ### What does Forward Ventures invest in? Forward Ventures invests most often at Series B and Series A (54% of the rounds on record), in sectors such as Transcriptomics, Therapeutic and Genomics. ### How active is Forward Ventures? 38 investments on record, 0 of them in the last 12 months. The most recent was in Aug 2015. ### How big are Forward Ventures's cheques? The median round it joins is $24M. ### Does Forward Ventures lead rounds? Rarely, if at all: none of its 38 investments on record names it as the lead. ### Where does Forward Ventures invest? Most of the companies it backs are in the United States (97%). ### Is Forward Ventures investing now? No investments in the last 12 months; the latest was in Aug 2015. ### Who does Forward Ventures invest alongside? Most often Domain Associates (7 rounds together), Gimv (7 rounds together) and MPM Capital (6 rounds together). ### What kind of investor is Forward Ventures? Forward Ventures is an accelerator based in San Diego, United States. ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=forward-ventures) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=forward-ventures)